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Available online 21 December 2010Mutations in UNC13D cause the severe immune disorder familial haemophagocytic
lymphohistiocytosis type 3 (FHL3). The gene product munc13-4 is expressed in hematopoietic
cells and is essential for degranulation. Little information is available on genotype–phenotype
relationships of UNC13D mutations. Some mutants may have residual functionality which
qualiﬁes them as promising targets for attempts to enhance function pharmacologically. A
problem for such analysis is the scarcity of patientmaterial.We established assays in the RBL-2H3
cell line to assess functionality of lentivirally transducedmunc13-4mutants. The basic principle of
which is to silence endogenous rat munc13-4 and replace it with siRNA resistant YFP-tagged
human variants. Localization, degranulation, and membrane binding kinetics can now easily be
analyzed quantitatively. Such a system might also be useful to screen small molecular weight
compounds for their ability to rescue degranulation in cells with reduced functional munc13-4.
© 2010 Elsevier B.V. Open access under the Elsevier OA license.Keywords:
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RBL-2H31. Introduction
FHL is a genetically heterogeneous disorder, characterized by
defective cytotoxic T lymphocyte (CTL) and natural killer (NK)
cell activity, and hypercytokinaemia (Arico et al., 1988; Henter
et al., 1991; Filipovich, 2006). FHL is fatal unless treated by
immune suppression and hematopoietic stem cell transplanta-
tion (Cesaro et al., 2008; Ohga et al., 2010). FHL links to ﬁve
genetic origins: chromosome 9, PRF1, UNC13D, STX11 and
STX11BP2 (Stepp et al., 1999; Feldmann et al., 2003; zur Stadt
et al., 2005, 2009). Mutations in UNC13D are classiﬁed as FHL3
and the protein munc13-4 is necessary for maturation of lytic
granules and for their docking at the immunological synapse
(Feldmann et al., 2003; Menager et al., 2007).
Munc13-4 involvement in secretory lysosome release has
been established in neutrophils, platelets, NK cells, CTL, and RBL-
2H3 cells (Feldmann et al., 2003; Shirakawa et al., 2004; Neeft
et al., 2005; Pivot-Pajot et al., 2008). The RBL-2H3 cell line hasphohistiocytosis.
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(Kapp-Barnea et al., 2003; Nomura et al., 2009; Tadokoro et al.,
2010), and the functional analysis of ectopically expressed
perforin mutations (Risma et al., 2006). The cells exhibit
properties commontobasophils andmast cells; bothdegranulate
after dimerization of the IgE bound FcεRI bymultivalent antigens
(Kepley et al., 1998; Gilﬁllan and Tkaczyk, 2006). Proximal
signalling of the receptor leads to activation of PKC and elevated
levels of Ca2+. Secretory lysosomes release their content by non-
polarized compound exocytosis that is microtubule dependent
and regulated by rab27a/b (Rohlich et al., 1971; Roa et al., 1997;
Smith et al., 2003;Nomura et al., 2009).Many components of the
signalling and fusion machinery are shared with CTL. The
degranulation pathway of RBL-2H3 cells therefore provides a
relevant immunological model system to study the functionality
of munc13-4 and FHL3 mutants.
Mutations in UNC13D are scattered over the entire gene
sequence and do not seem to cluster in speciﬁc areas (Santoro
et al., 2006; Rudd et al., 2008). They cause single amino acid
substitutions, frame shifts, deletions and premature stop codons
and might be responsible for the different onset and outcome of
FHL3. This diversity impairspredictionofdisease severitybygene
analysis. Thorough analysis of patientmaterial is often hampered
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goes beyond expression at mRNA and protein levels, and derives
mainly from the JINX mouse (Crozat et al., 2007). We therefore
established a robust knock-in system in which silencing of
endogenous munc13-4 is combined with stable lentiviral
transduction of YFP-tagged munc13-4 constructs. Advantages
of this platform include the application of versatile cell assays to
quantitative (residual) munc13-4 function, and to rank severity
of FHL3 mutations. It also offers the possibility to test small
molecularweight compounds for their ability to restore secretory
lysosome degranulation in FHL3.
2. Materials and methods
2.1. Antibodies and reagents
Antibodies were obtained from the indicated sources: p80
mouse hybridoma 5G10 (J. Bonifacino, NIH Bethesda), mouse
anti serotonin (DAKO), mouse anti rat CD63 (BD Biosciences),
mouse IgE anti DNP clone SPE-7 and corresponding antigenHSA-
DNP (Sigma), mouse anti GFP (Roche), conjugated secondary
antibodies (Jackson Immuno Research Laboratories). The rabbit
antibody against munc13-4 has been described (Neeft et al.,
2005). Following plasmids were generously provided by indi-
cated colleagues: peYFP-N1-Munc13-4 cDNA (V.Gerke, ZMBE
Münster), pLNT-SFFV-WPRE-Gateway (G. Grifﬁths, CIMR Cam-
bridge), lentiviral helper plasmids psPAX2 and pMD2.G
(A. Mertens UMC Utrecht). cDNAs encoding human munc13-4
and munc13-4-Δ608-611 were generated previously in this lab
(Neeft et al., 2005).
2.2. Cell culture
The RBL-2H3 cell line was generously provided by Ronit Sagi
Eisenberg (Tel Aviv University) and cloned by limited dilution to
obtain clones in which β-hexosaminidase secretion could be
stimulated to yield at least 30% release. The cellswere cultured in
DMEM containing 1 mgml−1 glucose, 10% heat-inactivated FCS
(Bodinco), 100 Uml−1 penicillin, 100 μg ml−1 streptomycin,
2 mM L-glutamine, 50 nM 2-mercaptoethanol and passaged 3
times a week 1/20. Degranulation of RBL-2H3 cells is inﬂuenced
by FCS and care was taken to obtain a batch that did not affect
degranulation. HEK293T were cultured in DMEM (Invitrogen)
5 mg ml−1 glucose, 10% heat-inactivated fetal calf serum
(Sigma), 100 Uml−1 penicillin, 100 μg ml−1 streptomycin and
2 mM L-glutamine.
2.3. Lentivirus preparation
YFP-tagged munc13-4 cDNAs were extended with attB
sites for cloning in pDONr201 (Invitrogen). After ampliﬁca-
tion inserts were transferred to the lentiviral plasmid pLNT–
SFFV–WPRE–Gateway (Demaison et al., 2002) using LR
Clonase II (Invitrogen). This lentiviral plasmid was developed
to induce gene expression in hematopoietic cells using a
spleen focus forming virus (SFFV) promoter, Woodchuck
hepatitis virus posttranscriptional regulatory element
(WPRE), central polypurine tract (cPPT) and appended with
a gateway cloning cassette between the long terminal repeats
(LTR). Primers GGGGACAAGTTTGTACAAAAAAGCAGGCTT-
CATGGTGAGCAAGGGCGAGGAGCTG (f), GGGGACCACTTTGTA-CAAGAAAGCTGGGTCCTACGGTGCCGGCCGCAAGGC (r) were
used for YFP on the N-terminus, and GGGGACAAGTTTGTA-
CAAAAAAGCA GGC TTCATGGCGA CACTCCTCTCCCATCC (f), and
GGGGACCACTTTGTACAAG AAAGCTGGGTCTTACTTGTA-
CAGCTCGTCCATGC for YFP at the C-terminus. All constructs
obtained through PCR were veriﬁed by sequencing. VSV-G
pseudotyped lentivirus was prepared in low passage number
HEK293T cells. To this aim 3×106 cells were seeded in a 10 cm
dish and transfected the next daywith 16 μg 1/1.1 ratio of pLNT–
SFFV–WPRE–cDNA, the packaging plasmid psPAX2 and pMD2.G
using calcium phosphate transfection. After 18 h medium was
replaced with 6ml freshmedium. Twenty four hours later, virus
was harvested and newmedium added for a ﬁnal period of 24 h.
Virus containing supernatants were stored at 4 °C, pooled and
ﬁltered through 0.2 μm. Virus stocks were concentrated 100 fold
by centrifugation for 2 h at 25,000 rpm in a SW-28 rotor. The
concentration procedure removedHEK293Tmediumwhichwas
detrimental to normal RBL-2H3 growth. Virus was resuspended
in 0.01 volume RBL-2H3 medium supplemented with 20 mM
Hepes pH 7.6, aliquotted and stored at −80 °C. Virus efﬁciency
was determined by titration on HEK293T and RBL-2H3 cells
through ﬂuorescence microscopy and western blot detection.
2.4. Generation and maintenance of stable RBL-2H3 lines
RBL-2H3 cells stably expressing lentiviral constructs were
made by infecting a 50% conﬂuent 10 cm dish with 10 μl of
concentrated virus in the presence of 6 μg ml−1 polybrene in
10 ml medium. Medium was replaced after 24 h and cells were
allowed to expand for another 24 h. Cellswere then cultured and
evaluated for expression. Typical transduction efﬁciencies were
70%. Cellswere collectedafter twoweeks for FACS sortingandwe
sorted a 99% positive cell population of at least 5×105 cells using
a FACSAria (BD). Cells were then transferred to 10 cm dishes for
maintenance culture. Lentiviruses reverse transcribe their RNA
and integrate the newly made DNA into the chromatin
(Bukrinsky et al., 1993). In our hands selection or resorting was
not neededwithin 2 months after transduction, since expression
levels remained constant during this period. If expression drops
however, cells can easily be sorted as above to enrich for
transfectants with higher expression.
2.5. Western blot and siRNA
For Western blot, 1×106 RBL-2H3 cells were lysed in 250 μl
1% Triton X-100, 100 mMNaCl, 50 mMTris–HCl pH 7.6. Lysates
were cleared by centrifugation and collected in 5× Laemmli
buffer containing 10% SDS, 50% glycerol, 0.625 M Tris–HCl pH
6.8, 250 mM DTT 0.01% Bromophenol blue. Samples were
electrophoresed through 7.5% SDS-PAA gels and blotted on
Immobilon-FL PVDF (Millipore). Blots were analyzed for
munc13-4, YFP and actin using primary antibodies described
above. Secondary alexa680 or IrDye800 ﬂuorescent antibodies
were used for detection in theOdyssey imaging system(Li-Cor).
Antibody incubations were typically 45 min, followed by three
washing steps in blocking buffer (Li-Cor). siRNA depletion of
endogenous ratmunc13-4 in RBL-2H3 cells was done through a
sequence targeting the ORF of rat munc13-4; GGAACAA-
GAUUUUUCACAAtt (Applied Biosystems). The siRNA was
introduced using AMAXA nucleofection (Lonza), 100 μl buffer
T, protocol X-001 according to manufacturers' instructions.
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(400 pmol), seeded in 2 ml full medium in a 6 cm dish and
grown for 48 h, knock-down efﬁciency was typically over 90%.
2.6. Immunoﬂuorescence microscopy
Transfected RBL-2H3 cells were grown on coverslips, ﬁxed
for 20 min at room temperature using 3% paraformaldehyde
and blocked in 0.5% BSA, 0.1% saponin in PBS. Cells were
subsequently incubated with primary and ﬂuorescently
labelled secondary antibody for 45 min. Unbound antibodies
were removed by washing with blocking buffer. Coverslips
were washed and mounted using Prolong gold (Invitrogen).
Imaging was performed on a Zeiss LSM 510 confocal
microscope equipped with a Ar/Kr laser for 488 nm and a
He–Ne laser for 543 nm, using a Plan-Apochromat 63×/1.40
oil objective. Microscope parameters were set to detect
optimal signals below the saturation limits. Quantitation of
overlapping signals in different channels was done with the
colocalization tool of ImageJ and expressed as Pearson's
coefﬁcient (Bolte and Cordelieres, 2006).
2.7. Degranulation assay
RBL-2H3 cells (2×106) were washed in 1 ml DMEM
containing 1% FCS (SDMEM) and incubated for 30 min at
37 °C in 0.5 ml SDMEM containing 50 ng ml−1 IgE anti DNP.
RBL-2H3 loaded with IgE anti DNP can be activated by
multivalent DNP–HSA conjugate. Cells were washed, and
triplicate samples of 150 μl were incubated for 1 h at 37 °C in
SDMEM containing 500 ngml−1 DNP–HSA. Incubations with
HSA (spontaneous release), and 0.2% TX-100 (total lysis) were
used as negative and positive control, respectively. 50 μl
supernatant was harvested and added to 50 μl 2 mM
p-nitrophenyl-N-acetyl-β-D-glucosaminide (Sigma) for 1 h at
37 °C in a 96-well plate. β-hexosaminidase activity was
determined colorimetrically at 405 nm after adding 150 μl
0.1 M carbonate buffer pH 10. Alternatively, degranulation
was induced by 100 nMphorbol 12-myristate 13-acetate (PMA,
Sigma) and 1 μM ionomycin (Calbiochem) with DMSO as
negative control and β-hexosaminidase release was assayed
as above.
2.8. Fluorescence recovery after photobleaching (FRAP)
FRAP was determined on live cells using a Zeiss LSM510
microscope with live cell imaging chamber at 37 °C and 5% CO2.
RBL-2H3 grown on 25 mm coverslips were transferred to
imaging chambers ﬁlled with 750 μl SDMEM for FRAP experi-
ments. Activation of cells was done by adding 250 μl SDMEM,
4 μM ionomycin, 400 nM PMA, 800 nM FM4-64 to the live cell
imaging chamber. Cells were activated pharmacologically to
induce a faster and more homogeneous response. Imaging was
started 90 s after the addition of the drugs, when most cells
showed ﬁrst signs of degranulation. Frameswere recorded in the
red (560 nm long pass) and green (505–530 nm band pass)
channel every 3 s. Bleach settings were 8 pulses of the 488
laserline at max laser power after the ﬁrst 5 frames. Cells were
imaged for 3 min after bleaching. Recovery was determined as
the recovery of the ﬂuorescence in the region of interest
corrected for the background signals outside the cells and forloss ofﬂuorescenceusing aROI of thewhole cell. The signal of the
dye FM4-64 was used to distinguish activated from resting cells.
Very little FM4-64 is found intracellularly ina restingcell,while in
activated cells fusion of vesicles and subsequent membrane
closure at the plasma membrane permit the dye to enter.
Recovery curves were drawn in Excel, and ﬁtted to a mono
exponential equation from which recovery parameters were
calculated with Origin 6.1 (OriginLab).
3. Results
3.1. Preparation of cell lines
The involvement of munc13-4 in degranulation has been
ﬁrmly established in a number of haematopoietic cell lines. We
originally detected high levels of munc13-4 in RBL-2H3 cells and
showed that it has a positive role on stimulus induced
degranulation (Neeft et al., 2005). Given the ease of culturing
andexperimentalmanipulation,weused theRBL-2H3as amodel
cell line for characterization of munc13-4. To establish the
analytical methods we chose three constructs: YFP-Munc13-4,
Munc13-4-YFP and YFP-Munc13-4Δ608-611 (YFP-Δ608-611).
The latter represents a FHL3 mutant which contains an in frame
internal deletion of 3 amino acids andwas used here for proof of
principle purposes because it exhibits a robust morphological
phenotype (Neeft et al., 2005). Fluorescent protein tags may
interfere with functionality of proteins and it has not been
rigorously established whether N- or C-terminal fusion proteins
of munc13-4 and YFP are functionally equivalent (Neeft
et al., 2005; Stevens et al., 2005). We therefore prepared N- and
C-terminally YFP-tagged wild type munc13-4 constructs to
directly test their behavior in several assays reporting on
munc13-4 features.
Reproducibility in single cell assays can be improved by
generating stable cell lineswith high transfection efﬁciency and
uniformexpressionon aper cell basis. Sinceelectroporation and
cationic lipid transfection methods did not meet these criteria,
we cloned munc13-4 cDNAs in the pLNT–SFFW–WPRE lenti-
viral expression plasmid (Fig. 1A). This plasmid enables
genomic integration in non-dividing cells and makes use of a
viral promoter that ensures expression in hematopoietic cells
(Bukrinsky et al., 1993; Demaison et al., 2002). VSV-G
pseudotyped lentiviral vectors were created in HEK293-T cells
and concentrated 100 times for infection of RBL-2H3. Expres-
sing populations were enriched by sorting using FACSaria to
obtain a 99% positive cell population. Integration of sequences
into a host genome can impair function of the gene at the
integration site (Wentzensen et al., 2004). To minimize
potential effects of clonal expansion of a single interrupted
gene, we sorted at least 5×105 cells. The stable introduction of
munc13-4 constructs did not affect cell growth. Transfection
efﬁciency was above 93% after one month of culturing without
selection drug (Fig. 1B).
We checked expression of munc13-4 in the sorted cell lines
by Western blot (Fig. 2A). YFP-tagged munc13-4 forms run at
140 kDa. ForYFP-munc13-4wedetectedadegradationband that
ran close to the position of endogenous munc13-4 at 110 kDa.
The expression levels ofmunc13-4-YFP and YFP-Δ608-611were
somewhat lower than of YFP-munc13-4 suggesting that they
have a higher turnover rate than YFP-munc13-4. Attempts to
enhance their expression usingmore virus and FACS enrichment
Fig. 1. Cloning strategy and sorting of stable RBL-2H3 cell lines. Layout of the lentiviral plasmid pLNT showing regulatory elements, the Gateway cloning site and
the three cDNAs that were introduced for stable cell line generation (A). Transfected and sorted cells were evaluated with FACS after a month to test stability of
expression. Fluorescent signals in FL-1 (530 nm) of nontransfected cells RBL-2H3 (blue), intermediate expression of munc13-4-YFP (black) and YFP-Δ608-611
(green) and high expression of YFP-munc13-4 (red) (B).
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different results obtainedwith the YFP tag onN- or C-terminus of
munc13-4 therefore suggested that C-terminal tagging increased
turn-over of munc13-4. We showed before that YFP-Δ608-611
does not bind membranes because its conformation is altered
which also might reduce its stability (Neeft et al., 2005).
3.2. Localization of munc13-4
YFP-munc13-4 and His6munc13-4 localize to secretory
lysosomes after transfection of RBL-2H3 cells by electroporation
(Neeft et al., 2005). The observation that munc13-4-YFP
consistently gave a somewhat lower expression than YFP-
munc13-4 (Fig. 2A), suggested that the C-terminal tag might
interfere with the function of munc13-4. Earlier studies found
munc13-1-GFP to localize to the plasma membrane of adrenal
medulla chromafﬁn cells. Munc13-1-GFP also supports the
priming of large dense core vesicle for exocytosis (Ashery et al.,
2000; Madison et al., 2005), but since the Sindbis system drives
very high expression, partial loss of function might be
compensated for by overexpression. To begin to address the
comparative functionality of N-, or C-terminally tagged
munc13-4, we assessed their intracellular distribution. The
transduced RBL-2H3 cell lines were prepared for ﬂuorescence
microscopy and labeled for CD63, and serotonin (Neeft et al.,
2005). The ﬁrst represents a typical membrane marker forlysosomes, while serotonin is stored within the lumen of
secretory lysosomes. Quantitation of colocalization with ImageJ
showed that nearly all (85±4%) of CD63-labeled structures
were positive for YFP-munc13-4 (Fig. 2B), which implies that
munc13-4 is located on a subset of lysosomes in RBL-2H3 cells.
The secretory lysosomes in RBL-2H3 that labeled for serotonin
are all positive for YFP-munc13-4 (Fig. 2C). The munc13-4-YFP
construct also localized to CD63 and serotonin structures, but
intensity of the signal was lower as was expected from the
expression data (Fig. 1B) and the extent of colocalization was
slight less (68±6%) than for YFP-munc13-4. We did not
observe differences in the ratio of membrane-bound versus
cytoplasmic ﬂuorescence signals between the munc13-4 con-
structs with the tag at N or C-terminus. We also used lentiviral
expression to assess thedistributionof YFP-Δ608-611. The FHL3
mutant distributed exclusively in the cytoplasm, and was not
found on the CD63 and serotonin positive structures, in
agreement with our previous results using transient transfec-
tion (Neeft et al., 2005).
3.3. Rescue assay β-hexosaminidase
Stimulated release of β-hexosaminidase from secretory
granules is a sensitive read-out of degranulation efﬁciency.
Our experimental strategy to use the RBL-2H3 cell line for
complementation experiments of degranulation relied on the
Fig. 2. Expression and localization of munc13-4 constructs in RBL-2H3. RBL-2H3 cells stably transduced with lentiviruses and sorted for YFP-signal were used for
Western blot detection of munc13-4 and actin. Open and closed arrow heads indicate positions of ectopically expressed and endogenous munc13-4, respectively.
The asterisk marks a degradation product of YFP-munc13-4 close to the endogenous munc13-4 (A). Confocal images of exogenous munc13-4 (green) localization
in RBL-2H3 labeled for rat CD63 (red). Scale bars are 5 μm(B). Confocal images of exogenousmunc13-4 (green) localization in RBL-2H3 labeled for serotonin (red).
Scale bars are 5 μm, and images are from a single optical section (C).
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then to selectively knock down endogenous munc13-4.
Because human munc13-4 and rat munc13-4 (rmunc13-4)
sequences are 86% identical, they very likely serve identical
functions. The region in rmunc13-4 that is targeted by the
siRNA, has 3 mismatches with the corresponding sequence in
munc13-4, rendering the latter resistant to the siRNA. Indeed,
while knock-down efﬁciency of rmunc13-4 is 90% using
Amaxa electroporation (Fig. 3A), YFP-hmunc13-4 expression
was not affected by the siRNA, nor was knock-down of
rmunc13-4 diminished when a full length hmunc13-4
construct was expressed (Fig. 3A). Transduction with the
munc13-4 constructs yielded uniform expression (Fig. 1B).
Over 99% of the cells in the lentivirally transduced RBL-2H3
cell lines expressed the transfected cDNA product, ensuring
that results of bulk assays are not obscured by contamination
with non-transfected cells. We then determined degranulation
efﬁciency of RBL-2H3 cells with silenced munc13-4. The cells
were activated with IgE anti DNP/DNP-HSA, and β-hexosamin-
idasewasmeasured colorometrically inmedium and in the cells.
The releaseofβ-hexosaminidasewasdiminishedby80%(Fig. 3B)
showing thatmunc13-4 is essential for degranulation inRBL-2H3
cells. In cells expressing YFP-munc13-4 we obtained a complete
rescue of the β-hexosaminidase secretion defect. In contrastmunc13-4 with YFP at the C-terminus was ~50% less effective.
Cells expressing munc13-4-YFP released β-hexosaminidase to a
lesser extent than cells treated with a scrambled siRNA. Thus
even though there was more munc13-4-YFP than endogenous
levels in the control cells, degranulation nevertheless was
impaired (Fig. 2A), strongly suggesting that positioning of the
YFP-tag at the C-terminus affected the function of the protein.
The FHL3 mutant YFP-Δ608-611 failed to rescue the secretion
defect since the extent of β-hexosaminidase release was
statistically not different from cells with silenced munc13-4
(Fig. 3B). In summary the complementation of degranulation
assay in RBL-2H3 cells faithfully recapitulated the secretion
phenotype of FHL3 mutations in cytotoxic lymphocytes.
RBL-2H3 cells can also be triggered to degranulate by
ionomycin and PMA. This treatment elevates intracellular
calcium and activates PKC, independent of FcεRI signaling
pathways. We performed the degranulation assays using
this experimental regimen and found that cells released
more β-hexosaminidase than after triggering via FcεRI (cf
siRNA bars in Fig. 3B and C). Evidently PMA/ionomycin
releases β-hexosaminidase not only from stores that are
regulated via FcεRI signaling and munc13-4. In agreement
with this notion, the effect of munc13-4 knock down is similar
as in Fig. 3B, but a substantial fraction of β-hexosaminidase can
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has also been observed in mast cells isolated from VAMP8
knock-out mice, and suggests that munc13-4 regulates secre-
tion of a subset of secretory granules in RBL-2H3 (Puri and
Roche, 2008). Under these conditions munc13-4-YFP rescued
secretion equally well as YFP-munc13-4, suggesting that loss of
munc13-4 function due to the C-terminal tag can be compen-sated for. Again we observed that the FHL3 mutant did not
rescue. Thus both activation methods can be used in the
complementation assay. The physiological pathway via the
FcεRI however has the advantage that it can better resolve
differences because functionality of munc13-4 constructs.
3.4. Fluorescence recovery after photobleaching
Munc13-4was initially puriﬁed from cytosol but localizes to
granules in microscopy assays (Neeft et al., 2005). The MHD
domains of munc13-4 are for required membrane-attachment,
which might be co-regulated by the Ca2+ containing C2B
domain that associates speciﬁcally with PIP and PIP2 lipids
(Shin et al., 2010). Because munc13-4 also lacks a membrane
anchor, it likely behaves as a peripheralmembrane protein that
can be exchanged from membranes to the cytoplasm. The
dynamics of this process can be regulated through signaling
pathways and associations with other proteins. We investigat-
ed the exchange rates of munc13-4 using ﬂuorescent recovery
after photobleaching (FRAP). With FRAP we can bleach YFP-
munc13-4 that is on membranes and record the kinetics and
level of recovery onto membranes. Recovery occurs when
molecules that are released from themembrane are exchanged
with those of the cytosol. We adjusted the LSM live cell
microscopys system to image at 1.5 s per frame, and collected
YFP (green) and FM4-64 (red) signals in subsequent frames.
Themunc13-4 signal on the larger granules (N0.5 μm) could be
easily detected using low laser power and resolution settings.
These structures display limited mobility which renders them
less likely to move out of the region of interest during imaging.
In the stable cell lines without rmunc13-4, distinct granular
structures were bleached and recovery of ﬂuorescent signal on
these structures was measured. Two parameters can be
derived; ﬁrst the percentage of recovery, which indicates the
fraction of freely exchangeable molecules on the membrane
and second the halftime of recovery, the time when half of the
intensity is recovered, representing the on/off rate. In resting
RBL-2H3 cells, YFP-munc13-4 recovery is 76±3% with a
halftime of recovery (t1/2) of 54±1 s (Fig. 4A–C), indicating a
transient binding with high exchange rates of munc13-4.
Munc13-4-YFP recovered to 79±1% with a t1/2 of 48±3 s
(Fig. 4A, B, D). The higher exchange rate of munc13-4-YFP
compared to YFP-munc13-4, likely reﬂects less tight binding to
the membrane induced by the C-terminal YFP-tag.
Activationof RBL-2H3 leads to fusionof secretory lysosomes
with the plasma membrane. If munc13-4 is involved in theFig. 3. Rescue of secretion in RBL-2H3 after knock-down of endogenous
munc13-4. RBL-2H3 cells stably transfected with lentivirus and sorted for
munc13-4 were treated with a siRNA targeting munc13-4 or control siRNA.
Cell lysates were used for Western blot detection of munc13-4 and actin.
Quantiﬁcation showed that the siRNA gave 90% knock down of rat munc13-4.
Open and closed arrow heads denote ectopically expressed and endoge-
nous munc13-4. The dot next to the YFP-munc13-4 lane indicates a
degradation product with mobility close to that of endogenous munc13-4
(A). β-hexosaminidase secretion after activation of RBL-2H3 by FcεRI
crosslinking was measured in control, knock down and rescue conditions.
The extent of released β-hexosaminidase is expressed as % of the total amount
of β-hexosaminidase that is present in the cells. Samples are averages of four
independent experiments, *pb0.05, ** pb0.005 (B). β-hexosaminidase
secretion after activation of RBL-2H3 by ionomycin and PMA was measured
in control, knock down and rescue conditions. Samples are averages of two
independent experiments (C).
Fig. 4. FRAP on munc13-4 in RBL-2H3 shows munc13-4 binding after activation. YFP-positive secretory lysosomes were bleached as described in the Materials and
methods section and recovery of ﬂuorescence was measured over time to evaluate protein exchange on themembrane of secretory lysosomes. FRAP experiments were
performedon resting anddegranulating cells. Activated cellswere identiﬁedby intracellular FM4-64 stainingas described in theMaterials andmethods section. Recovery
percentages forYFP-munc13-4,munc13-4-YFPandYFP-Δ608-611(A), halftimeof recovery for YFP-munc13-4,munc13-4-YFP andYFP-Δ608-611 (B). Recovery curves of
YFP-munc13-4 (C) and munc13-4-YFP (D) in resting and activated cells. RBL-2H3 YFP-munc13-4 cells labeled with FM4-64 dye in resting and activated state (E). Error
bars denote SEM of three independent experiments. Scale bars are 5 μm.
64 E. Elstak et al. / Journal of Immunological Methods 365 (2011) 58–66process of trans SNARE complex formation, it might become
more tightly bound to membranes. Cells were activated using
ionomycin and PMA, which orchestrates a highly synchronized
secretory response. Cells were co-incubated with FM4-64
during activation because it allows for the positive identiﬁca-
tion of an activated cell during image collection. The lipid dyeinserts in the plasma membrane but does not transverse it
(Fig. 4E top). Upon activation, secretory lysosomes fuse with
the plasmamembrane and as a consequence of which, become
accessible to FM4-64 (Fig. 4E, bottom).We found that recovery
was reduced to 60±1% (YFP-munc13-4) and 59±7%
(munc13-4-YFP), which implies that an increased fraction of
65E. Elstak et al. / Journal of Immunological Methods 365 (2011) 58–66the munc13-4 molecules can no longer be exchanged from
membranes (Fig. 4A, C, D). The t1/2 is increased to 60±2 s
(YFP-munc13-4) and 63±5 s (munc13-4-YFP), suggesting
tighter binding of munc13-4 with the secretory lysosome
membrane. The difference in t1/2 of YFP-munc13-4 and
munc13-4-YFP is diminished after activation (Fig. 4B), which
agrees well with changes seen on β-hexosaminidase release.
The FHL3mutant YFP-Δ608-611 did not localize tomembranes
and recovery resembles that of a cytosolic molecule with free
diffusion, resulting in diffusion like kinetics that approach
effective diffusion models (Fig. 4A, B) (Sprague et al., 2004).
4. Discussion
FHL3 is a severe genetic disorder caused by mutations in
UNC13D which codes for an essential factor in degranulation
of cytotoxic lymphocytes (Feldmann et al., 2003). A hallmark
of the disease is the uncontrolled proliferation of activated
lymphocytes and histiocytes that invade healthy organs as
liver, spleen and brain. FHL3 usually presents before the age
of 2 and is fatal unless treated. UNC13D is a large 4.4 kb gene
with 32 exons, in which over 50 mutations have been
reported (Cetica et al., 2010). A number of which encode
point mutants or truncated forms of munc13-4. Information
on large scale phenotype–genotype correlations is not
available, and we know little about the properties of the
mutants that are expressed. This is in part caused by the
difﬁculty in obtaining sufﬁcient material from the young and
oftentimes very sick patients for research.
The RBL-2H3 cell line already showed its potential as a
model for the molecular analysis of ectopically expressed
perforin (FHL2) mutations (Shiver et al., 1992; Risma et al.,
2006; Voskoboinik and Trapani, 2006; Voskoboinik et al.,
2007). We extended its utility and here developed a simple
complementation assay to study the requirements of
munc13-4 in degranulation. The method relied on the stable
expression of YFP-munc13-4 constructs using lentiviral
transduction in combination with siRNA of endogenous
munc13-4. We showed here that the assay can be used for
the quantitative analysis of FHL3 mutants in secretory
lysosome degranulation. Other fundamental aspects of
munc13-4 function can also be investigated conveniently by
using this model system examples including its role in
maturation of secretory lysosomes (Menager et al., 2007)
and the function of munc13-4 in complex with its upstream
regulator rab27 in the degranulation process.
The RBL-2H3 assay also provides incentives for the develop-
ment of screens with small compound libraries to search for
drugs that can overcome degranulation defects caused by
expressed FHL3 mutants. These could be of biomedical utility
for designing novel therapeutic modalities towards FHL3.
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